Ying‐Cheng Chiang

3.1k total citations
85 papers, 1.8k citations indexed

About

Ying‐Cheng Chiang is a scholar working on Reproductive Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Ying‐Cheng Chiang has authored 85 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Reproductive Medicine, 24 papers in Molecular Biology and 22 papers in Oncology. Recurrent topics in Ying‐Cheng Chiang's work include Ovarian cancer diagnosis and treatment (29 papers), Endometrial and Cervical Cancer Treatments (19 papers) and Immunotherapy and Immune Responses (10 papers). Ying‐Cheng Chiang is often cited by papers focused on Ovarian cancer diagnosis and treatment (29 papers), Endometrial and Cervical Cancer Treatments (19 papers) and Immunotherapy and Immune Responses (10 papers). Ying‐Cheng Chiang collaborates with scholars based in Taiwan, United States and South Korea. Ying‐Cheng Chiang's co-authors include Wen‐Fang Cheng, Chi‐An Chen, Yu‐Li Chen, Ming‐Cheng Chang, Han-Wei Lin, Kuan‐Ting Kuo, Chang‐Yao Hsieh, Yi‐Jou Tai, Wei‐Zen Sun and Ming-Chieh Lin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ying‐Cheng Chiang

77 papers receiving 1.8k citations

Peers

Countries citing papers authored by Ying‐Cheng Chiang

Since Specialization

Citations

This map shows the geographic impact of Ying‐Cheng Chiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying‐Cheng Chiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying‐Cheng Chiang more than expected).

Fields of papers citing papers by Ying‐Cheng Chiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying‐Cheng Chiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying‐Cheng Chiang. The network helps show where Ying‐Cheng Chiang may publish in the future.

Co-authorship network of co-authors of Ying‐Cheng Chiang

This figure shows the co-authorship network connecting the top 25 collaborators of Ying‐Cheng Chiang. A scholar is included among the top collaborators of Ying‐Cheng Chiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying‐Cheng Chiang. Ying‐Cheng Chiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Warning factors of metachronous uterine cancer in patients with breast cancer: a real-world nationwide cohort study 2025 ·Gynecologic Oncology Reports ·Yi‐Jou Tai, (unknown), Yong‐Chen Chen, San‐Lin You, Ying‐Cheng Chiang	0
2	Whole exome sequencing-based homologous recombination deficiency test for epithelial ovarian cancer 2025 ·Journal of Ovarian Research ·Ying‐Cheng Chiang, (unknown), (unknown), Wuh‐Liang Hwu, Po‐Han Lin	0
3	Pembrolizumab combined with chemotherapy for advanced and recurrent endometrial cancer: A single-center retrospective study 2025 ·Journal of the Formosan Medical Association ·(unknown), Ying‐Cheng Chiang, (unknown), Annan Yang, (unknown), Lin‐Hung Wei, Bor‐Ching Sheu, Wen‐Chun Chang	2
4	Free-floating trophoblastic cyst in chemo-resistant gestational trophoblastic neoplasm 2025 ·International Journal of Gynecological Cancer ·(unknown), Ying‐Cheng Chiang	0
5	The Role of Chitinase-3-like Protein-1 (YKL40) in the Therapy of Cancer and Other Chronic-Inflammation-Related Diseases 2024 ·Pharmaceuticals ·Ming‐Cheng Chang, Chun-Tang Chen, (unknown), Ying‐Cheng Chiang	17
6	Diverse genetic spectrum among patients who met the criteria of hereditary breast, ovarian and pancreatic cancer syndrome 2023 ·Journal of Gynecologic Oncology ·Po‐Han Lin, Yu‐Wen Tien, Wen‐Fang Cheng, Ying‐Cheng Chiang, Chien‐Hui Wu, Karen Yang, Chiun‐Sheng Huang	2
7	Age-specific trend and birth cohort effect on different histologic types of uterine corpus cancers 2023 ·Scientific Reports ·Yi‐Jou Tai, Chun‐Ju Chiang, Ying‐Cheng Chiang, (unknown), Wen‐Chung Lee, Wen‐Fang Cheng	3
8	Develop companion radiopharmaceutical YKL40 antibodies as potential theranostic agents for epithelial ovarian cancer 2022 ·Biomedicine & Pharmacotherapy ·Ming‐Cheng Chang, (unknown), (unknown), Cheng‐Liang Peng, (unknown), Chia‐Yen Huang, Chi‐An Chen, Ying‐Cheng Chiang	3
9	Factors predicting parametrial invasion in patients with early-stage cervical carcinomas 2018 ·PLoS ONE ·Heng‐Cheng Hsu, Yi‐Jou Tai, Yu‐Li Chen, Ying‐Cheng Chiang, Chi‐An Chen, Wen‐Fang Cheng	13
10	Genomewide copy number analysis of Müllerian adenosarcoma identified chromosomal instability in the aggressive subgroup 2016 ·Modern Pathology ·Jen‐Chieh Lee, Tzu‐Pin Lu, Chun A. Changou, Cher‐Wei Liang, (unknown), (unknown), Hsuan‐Ying Huang, (unknown), Ying‐Cheng Chiang, Ben Davidson, Ming-Chieh Lin, Kuan‐Ting Kuo	20
11	Epigenetic silencing of BLU through interfering apoptosis results in chemoresistance and poor prognosis of ovarian serous carcinoma patients 2013 ·Endocrine Related Cancer ·Ying‐Cheng Chiang, (unknown), (unknown), Meei‐Maan Wu, Chang‐Yao Hsieh, Wen‐Fang Cheng, Chi‐An Chen	16
12	Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations and ZNF217 amplification in ovarian clear cell carcinoma 2013 ·Modern Pathology ·(unknown), Ming-Chieh Lin, Wen‐Chih Huang, Ying‐Cheng Chiang, Kuan‐Ting Kuo	72
13	High-risk human papillomavirus, other than type 16/18, in predominantly older Taiwanese women with high-grade cervical preinvasive lesions 2013 ·Taiwanese Journal of Obstetrics and Gynecology ·Ying‐Cheng Chiang, Wen‐Fang Cheng, Yu‐Li Chen, Ming‐Cheng Chang, Chang‐Yao Hsieh, Ming-Chieh Lin, Chi‐An Chen	8
14	New primers for methylation-specific polymerase chain reaction enhance specificity of detecting STAT1 methylation 2012 ·Taiwanese Journal of Obstetrics and Gynecology ·(unknown), Ying‐Cheng Chiang, Chih‐Ming Ho, Yu‐Li Chen, Chi‐An Chen, Wen‐Fang Cheng, Cheng-Yang Chou	5
15	Serous ovarian carcinoma patients with high alpha‐folate receptor had reducing survival and cytotoxic chemo‐response 2011 ·Molecular Oncology ·Yu‐Li Chen, Ming‐Cheng Chang, Chia‐Yen Huang, Ying‐Cheng Chiang, Han-Wei Lin, Chi‐An Chen, Chang‐Yao Hsieh, Wen‐Fang Cheng	116
16	A long-term follow-up study of 176 cases with adult-type ovarian granulosa cell tumors 2011 ·Gynecologic Oncology ·Hsu‐Dong Sun, Hao Lin, (unknown), Kung-Liahng Wang, Wen-Shiung Liou, Yao‐Ching Hung, Ying‐Cheng Chiang, Chien‐Hsing Lu, (unknown), Mu‐Hsien Yu	91
17	Noncarrier naked antigen-specific DNA vaccine generates potent antigen-specific immunologic responses and antitumor effects 2009 ·Gene Therapy ·Chi‐An Chen, (unknown), Wei‐Zen Sun, Yi‐Lang Chen, Ying‐Cheng Chiang, C-Y. Hsieh, (unknown), (unknown), Wen‐Fang Cheng	12
18	Brain nociceptive imaging in rats using 18f-fluorodeoxyglucose small-animal positron emission tomography 2008 ·Neuroscience ·Yen‐Yu Ian Shih, Ying‐Cheng Chiang, (unknown), (unknown), (unknown), (unknown), Chen Chang, (unknown)	28
19	Septic Shock after Conservative Management for Placenta Accreta 2006 ·Taiwanese Journal of Obstetrics and Gynecology ·Ying‐Cheng Chiang, Jin‐Chung Shih, Chien‐Nan Lee	21
20	Tuberculosis peritonitis 2006 ·Surgery ·(unknown), Ying‐Cheng Chiang, Lin‐Hung Wei, Wen‐Jeng Lee, Kao‐Lang Liu	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact